Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 19, 2014
Previous Article Next Article

Dinuclear zinc(II) complexes containing (benzimidazol-2-yl)benzene that overcome drug resistance in hepatocellular carcinoma cells through induction of mitochondria fragmentation

Author affiliations

Abstract

Herein we demonstrated that dinuclear zinc complexes could overcome drug resistance in R-HepG2 drug resistance hepatocellular carcinoma cells through induction of mitochondria-mediated apoptosis or by triggering mitochondria fragmentation, depletion of the membrane potential and intracellular ATP levels.

Graphical abstract: Dinuclear zinc(ii) complexes containing (benzimidazol-2-yl)benzene that overcome drug resistance in hepatocellular carcinoma cells through induction of mitochondria fragmentation

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 20 Jan 2014, accepted on 27 Feb 2014 and first published on 03 Mar 2014


Article type: Communication
DOI: 10.1039/C4DT00198B
Citation: Dalton Trans., 2014,43, 6973-6976
  •   Request permissions

    Dinuclear zinc(II) complexes containing (benzimidazol-2-yl)benzene that overcome drug resistance in hepatocellular carcinoma cells through induction of mitochondria fragmentation

    Q. Xie, S. Liu, X. Li, Q. Wu, Z. Luo, X. Fu, W. Cao, G. Lan, D. Li, W. Zheng and T. Chen, Dalton Trans., 2014, 43, 6973
    DOI: 10.1039/C4DT00198B

Search articles by author